Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


World Health Organization

Cases of measles in Europe on track to double in 2019

MMR vaccine


“While take-up of the MMR vaccination [pictured] across the UK is still high, it is not high enough,” said Martin Marshall, vice chair of the Royal College of GPs

The World Health Organization (WHO) has recorded around 90,000 cases of measles in Europe in the first six months of 2019 — a higher figure than the 84,462 cases identified in the whole of 2018.

The figures, released by WHO on 29 August 2019, are based on an assessment of the 53 member states comprising the region by the European Regional Verification Commission for Measles and Rubella Elimination (RVC).

The RVC also confirmed that the UK, Albania, Greece and Czech Republic lost their measles-free status in 2018.

The WHO classes the current status of measles circulation in the European region as a grade 2 emergency , described as an event having moderate public health consequences, which allows the organisation to activate an emergency support team.

Zsuzsanna Jakab, regional director for Europe at the WHO, said: “Through activation of the emergency response, [the] WHO has increased its focus on measles elimination and upgraded its action.”

Martin Marshall, vice chair of the Royal College of GPs, described the RVC’s findings were as “disheartening”.

“While take-up of the MMR vaccination across the UK are still high, it is not high enough, and we have actually seen a small decline in recent years,” he said.

“It is clear that we are still suffering from entirely debunked claims around MMR that were perpetuated in the [1990s] — and are now resurgent on social media and other online platforms.”

However, Marshall said it was “encouraging that WHO has increased its focus on measles elimination and upgraded action to address the challenges which have allowed this deadly virus to persist in countries including the UK”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207007

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.